Yi Fang

1.2k total citations
63 papers, 928 citations indexed

About

Yi Fang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yi Fang has authored 63 papers receiving a total of 928 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Yi Fang's work include Bone Metabolism and Diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yi Fang is often cited by papers focused on Bone Metabolism and Diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yi Fang collaborates with scholars based in China and United States. Yi Fang's co-authors include Yiyang Hu, Jinghua Peng, Jing Leng, Huajie Tian, Jun Peng, Lihui Wei, Chi Yang, Xinhua Xu, Shihua Wang and Daojun Li and has published in prestigious journals such as PLoS ONE, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Yi Fang

58 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Fang China 18 451 173 143 130 74 63 928
Mohamed El‐Mesery Egypt 21 460 1.0× 188 1.1× 110 0.8× 197 1.5× 72 1.0× 62 1.2k
Naping Tang China 21 329 0.7× 235 1.4× 124 0.9× 144 1.1× 119 1.6× 44 1.2k
Lin Liao China 20 461 1.0× 82 0.5× 129 0.9× 129 1.0× 52 0.7× 106 1.1k
Chao Zheng China 21 454 1.0× 151 0.9× 130 0.9× 139 1.1× 69 0.9× 80 1.3k
Qichao Hu China 16 412 0.9× 106 0.6× 137 1.0× 212 1.6× 141 1.9× 43 1.0k
Kamil Biringer Slovakia 23 517 1.1× 157 0.9× 254 1.8× 122 0.9× 130 1.8× 69 1.4k
Hongxin Cao China 20 640 1.4× 165 1.0× 148 1.0× 81 0.6× 67 0.9× 57 1.1k
Julius Balogh United States 8 428 0.9× 147 0.8× 212 1.5× 247 1.9× 34 0.5× 27 1.1k

Countries citing papers authored by Yi Fang

Since Specialization
Citations

This map shows the geographic impact of Yi Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Fang more than expected).

Fields of papers citing papers by Yi Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Fang. The network helps show where Yi Fang may publish in the future.

Co-authorship network of co-authors of Yi Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Fang. A scholar is included among the top collaborators of Yi Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Fang. Yi Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Yi, et al.. (2025). Using machine learning models to predict the dose-effect curve of municipal wastewater for zebrafish embryo toxicity. Journal of Hazardous Materials. 488. 137278–137278. 2 indexed citations
2.
Fang, Yi, Yulun Wu, Lihui Wei, et al.. (2024). miR-326 overexpression inhibits colorectal cancer cell growth and proteasome activity by targeting PNO1: unveiling a novel therapeutic intervention strategy. Scientific Reports. 14(1). 24284–24284. 1 indexed citations
3.
Liu, Liya, Youqin Chen, S. B. Liu, et al.. (2024). Therapeutic potential of Pien Tze Huang in colitis-associated colorectal cancer: mechanistic insights from a mouse model. Cancer Cell International. 24(1). 250–250. 2 indexed citations
4.
Nie, Ke, Songtao Jia, Dan Liu, et al.. (2024). Comparative study of transcriptomic alterations in sepsis-induced acute liver injury: Deciphering the role of alternative splicing in mouse models. International Immunopharmacology. 146. 113878–113878.
5.
Liu, Liya, Yuying Han, Lihui Wei, et al.. (2024). Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway. Chinese Journal of Integrative Medicine. 30(6). 515–524. 3 indexed citations
6.
Shen, Aling, Meizhu Wu, Farman Ali, et al.. (2023). Based on network pharmacology, gastrodin attenuates hypertension-induced vascular smooth muscle cell proliferation and PI3K/AKT pathway activation. Scientific Reports. 13(1). 12140–12140. 7 indexed citations
7.
Wu, Meizhu, Siyu Zhang, Wenqiang Zhang, et al.. (2023). Qingda granule ameliorates vascular remodeling and phenotypic transformation of adventitial fibroblasts via suppressing the TGF-β1/Smad2/3 pathway. Journal of Ethnopharmacology. 313. 116535–116535. 7 indexed citations
8.
Cheng, Ying, Jianfeng Chu, Meizhu Wu, et al.. (2021). Baicalin attenuates angiotensin II-induced blood pressure elevation and modulates MLCK/p-MLC signaling pathway. Biomedicine & Pharmacotherapy. 143. 112124–112124. 26 indexed citations
9.
Zhang, Ling, Yi Fang, Jianyu Feng, et al.. (2017). Chloroform fraction of Scutellaria barbata D. Don inhibits the growth of colorectal cancer cells by activating miR-34a. Oncology Reports. 37(6). 3695–3701. 17 indexed citations
10.
Xu, Xinhua, Xiaoyan Liu, Jin Su, et al.. (2014). shRNA targeting Bmi-1 sensitizes CD44+ nasopharyngeal cancer stem-like cells to radiotherapy. Oncology Reports. 32(2). 764–770. 14 indexed citations
11.
Deng, Wei, Yi Fang, Yuan Liu, et al.. (2014). Sanguinarine protects against pressure overload-induced cardiac remodeling via inhibition of nuclear factor-κB activation. Molecular Medicine Reports. 10(1). 211–216. 9 indexed citations
12.
Fang, Yi, Youjun Feng, Tongjin Wu, et al.. (2013). Aflatoxin B1 Negatively Regulates Wnt/β-Catenin Signaling Pathway through Activating miR-33a. PLoS ONE. 8(8). e73004–e73004. 58 indexed citations
13.
Yang, Chi, Jue Fan, Zhenhong Zhuang, et al.. (2013). The role of NAD+-dependent isocitrate dehydrogenase 3 subunit α in AFB1 induced liver lesion. Toxicology Letters. 224(3). 371–379. 8 indexed citations
14.
Wu, Qingqing, Jing Zong, Lu Gao, et al.. (2013). Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy. Herz. 39(3). 390–396. 25 indexed citations
15.
Deng, Wei, Yi Fang, Heng Zhou, et al.. (2013). Hesperetin protects against cardiac remodelling induced by pressure overload in mice. Journal of Molecular Histology. 44(5). 575–585. 41 indexed citations
16.
Zhao, Qingyu, et al.. (2013). Perioperative Comprehensive Supportive Care Interventions for Chinese Patients with Esophageal Carcinoma: a Prospective Study. Asian Pacific Journal of Cancer Prevention. 14(12). 7359–7366. 24 indexed citations
17.
Ma, Gang, et al.. (2012). Dexmedetomidine versus Midazolam for Conscious Sedation in Postoperative Patients Undergoing Flexible Bronchoscopy: A Randomized Study. Journal of International Medical Research. 40(4). 1371–1380. 36 indexed citations
18.
Zong, Jing, Qingqing Wu, Heng Zhou, et al.. (2012). 3,3′-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5′-adenosine monophosphate-activated protein kinase-α. Molecular Medicine Reports. 12(1). 1247–1252. 14 indexed citations
19.
Su, Jin, Xinhua Xu, Qiao Huang, et al.. (2011). Identification of Cancer Stem-like CD44+ Cells in Human Nasopharyngeal Carcinoma Cell Line. Archives of Medical Research. 42(1). 15–21. 63 indexed citations
20.
Fang, Yi, Liying Wang, Jiawei Jin, & Xiliang Zha. (2001). Focal adhesion kinase affects the sensitivity of human hepatocellular carcinoma cell line SMMC‐7721 to tumor necrosis factor‐α/cycloheximide‐induced apoptosis by regulating protein kinase B levels. European Journal of Biochemistry. 268(16). 4513–4519. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed El‐Mesery Breakdown of academic impact, for papers by Naping Tang Breakdown of academic impact, for papers by Lin Liao Breakdown of academic impact, for papers by Chao Zheng Breakdown of academic impact, for papers by Qichao Hu Breakdown of academic impact, for papers by Kamil Biringer Breakdown of academic impact, for papers by Hongxin Cao Breakdown of academic impact, for papers by Julius Balogh
Rankless by CCL
2026